Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Ensysce Biosciences Inc (NASDAQ:ENSC) announced topline results from a human abuse potential (HAP) study for PF614.
- PF614 is a new class of analgesia, a Trypsin Activated Abuse-Protected (TAAP) oxycodone product.
- The HAP study was designed to test if known recreational drug users "liked" the product and is critical for new drugs in this class.
- The primary measure in this study, "drug liking," is known to correlate with a drug's potential for abuse.
- In the study, PF614 powder produced significantly lower peak "drug liking" when compared with intranasal crushed IR oxycodone.
- Furthermore, in the first-period analysis of initial impressions of each drug, a similarly strong difference was noted between PF614 (n=8) and crushed IR oxycodone (n=10), even with this smaller cohort of subjects.
- Related: Ensysce Biosciences, Quotient Partner To Work On Novel Opioid To Prevent Abuse and Overdose.
- Statistically significant differences in peak effects (Emax) between PF614 and crushed IR oxycodone intranasal were also demonstrated for the secondary endpoint of "take drug again," where PF614 produced only 27% as high an Emax score as crushed oxycodone among recreational drug users.
- Price Action: ENSC shares are up 11.10% at $3.45 session on the last check Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!